GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Other Income (Expense)

Novartis AG (Novartis AG) Other Income (Expense) : $-254 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Other Income (Expense)?

Novartis AG's other income expense for the Novartis AG's pretax income for the three months ended in Mar. 2024 was $-29 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-254 Mil.

Novartis AG Other Income (Expense) Historical Data

The historical data trend for Novartis AG's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Other Income (Expense) Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 659.00 538.00 15,268.00 -195.00 -227.00

Novartis AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.00 -2.00 -3.00 -220.00 -29.00

Novartis AG Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-254 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG  (OTCPK:NVSEF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Novartis AG (Novartis AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Other Income (Expense)
Comparable Companies
XSWX:ROG XSWX:COPN LLY JNJ MRK ABBV LSE:AZN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 BIIB XTER:BAYN TSE:4578 SHSE:600436
Traded in Other Exchanges
NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina
Address
Lichtstrasse 35, Basel, CHE, 4056
Website
https://www.novartis.com
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.